China TransInfo Technology (002373.SZ) Quick Take: Mixed 1Q25 Print – Op. Profit Miss but Earnings Beat on Investment Income CITI'S TAKE Flash | Transinfo reported 1Q25 results with 1Q25 revenue edging up 2% YoY to Rmb1.6bn, 18% ahead BBGe, and 1Q25 GM expanded 0.6ppts YoY to 29.7%, 4.6ppts below BBGe. 1Q25 opex stood at Rmb555mn (flat YoY), 34% higher than BBGe, thus the 1Q25 operating loss came in at Rmb77mn. Helped by the gain from a fair value change in investment of Rmb302mn, 1Q25 net profit was Rmb221 ...

Unchanged In-line Largely unchanged Impact to our thesis Financial results versus consensus Direction of next 12-month consensus EPS April 27, 2025 02:38 PM GMT Luzhou Lao Jiao Co. Ltd | Asia Pacific 2024/1Q25 Results in Line; Dividend Policy Announced Reaction to earnings Key Takeaways Revenue by price segment: Mid-high end liquor sales rose 3% yoy (88.4% of liquor sales) and low-end liquor sales increased 6% yoy in 2024. Margin trends: OPM declined 1.0ppt yoy in 1Q25, with narrowed GPM on a lower product ...

April 27, 2025 03:19 PM GMT Chongqing Changan Automobile (000625.SZ, 000625 Chongqing Changan Automobile | Asia Pacific Resilient 1Q performance, likely on the back of NEV advances Chang'an reported 1Q25 NPAT of Rmb1.35bn, representing YoY growth of 16.8% despite revenue slowing by 7.7% to Rmb34.1bn. We expect losses to narrow notably with respect to its NEV business, as seen by reduced minority interest (Rmb137mn in 1Q25 vs. Rmb302mn in 1Q24 and Rmb348mn in 4Q24, representing a loss to minority shareholder ...

J P M O R G A N Asia Pacific Equity Research 27 April 2025 This material is neither intended to be distributed to Mainland China investors nor to provide securities investment consultancy services within the territory of Mainland China. This material or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan. Wuliangye - A 2024 sales up 7.1% yoy at expense of relaxing credit & rising rebates to distributors; 2025 sales target of c5% (in line with GDP growth) ...

April 27, 2025 04:24 PM GMT Pharmaron | Asia Pacific 1Q25 Results First Take: Revenue In Line with MSe; New Order Growth Slightly Softer Than Expected Key Takeaways Geographical mix: 1Q25 revenue streams from North America, EU and China delivered YoY growth of 16.8%, 26.6% and 13.1%, accounted for c. 65%, 18% and 15% of total revenue, respectively with another 2% from rest of the world. Customer base: Revenue stream from top 20 pharma and other customers grew 29% and 14% YoY, respectively. Cash flow: Net op ...

Investment Rating - The report maintains a "Buy" rating for BYD with a target price of HKD 491.00 [6][21][19] Core Insights - BYD reported a revenue of CNY 170 billion in 1Q25, reflecting a year-on-year increase of 36% but a quarter-on-quarter decline of 38% due to a shipment of 1 million NEVs, which is a 60% increase year-on-year [1][8] - The gross profit margin (GPM) for BYD in 1Q25 was 20.1%, down 0.6 percentage points year-on-year, indicating ongoing fierce competition in the market [1][8] - Operating profit for BYD was CNY 5.6 billion, a 39% increase year-on-year, while net profit reached CNY 9.2 billion, doubling year-on-year [1][8] Summary by Sections Financial Performance - Revenue for 1Q25 was CNY 170.36 billion, a 36% increase year-on-year but a 38% decrease quarter-on-quarter [8] - Operating profit was CNY 5.6 billion, up 39% year-on-year, while net profit was CNY 9.2 billion, reflecting a 100% increase year-on-year [1][8] - The GPM was 20.1%, down from 20.7% in 1Q24, indicating a decline in profitability due to competitive pressures [1][8] Market Dynamics - The report highlights that BYD continues to benefit from its business scale despite a competitive environment, with sales and marketing expenses growing at a slower pace than revenue [1][4] - Recent government policies tightening smart driving function promotions have affected order volumes across the industry, prompting a shift in focus towards pricing strategies [2][3] Strategic Initiatives - BYD has initiated time-limited promotions with price cuts of 8-17% on select models to stimulate demand [4] - The company aims to improve liquidity through a proposed distribution of bonus shares, increasing the total number of shares from 3,039 million to 9,117 million [5][21]

Investment Rating - The report maintains a "Buy" rating for Aluminum Corp of China (Chalco) H/A shares, with target prices adjusted to HKD6.10 for H-shares and RMB9.80 for A-shares, implying upside potentials of approximately 42% and 48% respectively [5][40]. Core Insights - Chalco reported a net profit after tax (NPAT) of approximately RMB3.5 billion in 1Q25, reflecting a 5% quarter-on-quarter increase and a 59% year-on-year increase, attributed to better-than-expected sales volume and average selling prices (ASP) for aluminum and alumina [1][9]. - The company expects capital expenditures of RMB14.8 billion in 2025, focusing on wind power projects and new alumina production sites, while aiming to increase green power usage from 47% in 2024 to 55% in 2025 [2][9]. - Despite solid fundamentals for aluminum, earnings are expected to decline by approximately 12% in 2025 due to lower alumina prices, with the alumina price already below breakeven levels [3][9]. Financial Performance - In 1Q25, Chalco's sales volumes for self-produced aluminum decreased by 5% quarter-on-quarter, while alumina sales increased by 6% quarter-on-quarter. However, revenue and gross profits fell by 12% and 29% quarter-on-quarter respectively due to a significant drop in alumina prices [1][31]. - The company recorded a decrease in selling, general and administrative (SG&A) expenses by 6% year-on-year and 66% quarter-on-quarter, indicating effective cost control [1][31]. - Investment income rose by RMB0.37 billion in 1Q25, driven by higher alumina prices year-on-year and gains from hedging [36]. Production and Operational Strategy - Chalco's aluminum production operating rate reached 95% in China, supported by demand from electric vehicles, batteries, and solar products [3][9]. - The company plans to relocate alumina production from inland to coastal provinces to reduce transportation costs and expects to close down 1-2 million tons of alumina production in 2025 [2][34]. - Chalco aims to optimize its alumina capacity of 25 million tons by utilizing lower-cost imported bauxite, which may lead to some impairment losses [34]. Market Outlook - The report anticipates steady aluminum prices in 2025, supported by robust demand from the "New Three" sectors, while alumina prices are expected to have limited downside due to their current low levels [3][9]. - The coal price and electricity costs remained weak in 1Q25, which may benefit Chalco's operational costs [3][9].

Investment Rating - The report maintains a "Buy" rating for Kstar and Envicool, while Kehua is rated as "Neutral" [2][11]. Core Insights - The data center supply chain in China is experiencing strong demand, with expectations for continued capacity expansion through 2025 and potentially into 2026, despite challenges such as overseas chip supply constraints [1][5]. - The report has revised earnings per share (EPS) estimates downward by 17%-31% for Kstar, Envicool, and Kehua, primarily due to uncertainties in domestic solar inverter and energy storage system (ESS) demand, as well as intense pricing competition [1][7]. - Kstar is favored over Kehua due to its faster long-term growth potential, better margin profile, and more attractive valuation metrics [2][5]. Kstar Summary - Kstar's sales and net income for 4Q24 decreased by 9% and 76% year-over-year, respectively, while 1Q25 showed a 14% increase in sales but a 17% decrease in net income [5][8]. - The company anticipates 30%-50% year-over-year order growth from domestic internet and telecom customers in 2025, with significant opportunities for customer base expansion [6][9]. - Kstar's total revenue is projected to grow from Rmb 4.159 billion in 2024 to Rmb 9.642 billion by 2030, with a net income increase from Rmb 394 million to Rmb 1.455 billion over the same period [10]. Envicool Summary - Envicool's 4Q24 and 1Q25 results missed expectations due to delayed revenue recognition and increased operating expenses, leading to a 31% downward revision in EPS estimates [11][15]. - The data center room cooling segment saw sales growth of 49% in 2024, with a record high order backlog by 1Q25, indicating strong demand [13][14]. - Envicool's total revenue is expected to rise from Rmb 3.529 billion in 2024 to Rmb 4.589 billion in 2025, with net profit projected to increase from Rmb 344 million to Rmb 453 million [16].

Investment Rating - The report downgrades the investment rating of Sungrow Power Supply from Buy to Neutral, with a target price reduced from CNY 100 to CNY 58 [3][5][21]. Core Insights - The earnings for 1Q25 exceeded expectations due to strong growth in the energy storage system (ESS) segment, with revenue growth of 50.9% year-on-year [1]. - Despite strong shipment forecasts for 2025, the report expresses caution regarding potential earnings due to tariff headwinds and increased competition in emerging markets [2][3]. - The company has suspended ESS shipments to the US market, which typically offers better gross margins, impacting future earnings [2][3]. Summary by Sections Financial Performance - Sungrow reported 4Q24 revenue of CNY 27.9 billion, an 8.0% year-on-year increase, and 1Q25 revenue of CNY 19.0 billion, a 50.9% year-on-year increase [1]. - The net profit for 4Q24 was CNY 3,437 million, up 55% year-on-year, and for 1Q25, it was CNY 3,826 million, up 83% year-on-year [1]. Shipment Forecasts - For 2025, solar and ESS shipments are estimated at 160GW (up 9% year-on-year) and over 40GWh (up 43% year-on-year), respectively [2]. - The company reported solar inverter and ESS shipments of 147GW and 28GWh in 2024, aligning with previous estimates [1]. Valuation Metrics - The new target price of CNY 58 is based on a P/E ratio of 11.3x for 2025F, reflecting a decrease from the previous 16x due to anticipated margin pressures [3][13]. - The report indicates a projected normalized EPS decline from CNY 5.67 to CNY 5.12 for 2025F [3][4]. Market Context - The report highlights intensified competition in the Middle East market, which may further limit Sungrow's shipment and earnings growth in 2H25 [2]. - The company is facing challenges from increased anti-dumping and countervailing duties affecting solar module shipments to the US [2].

Investment Rating - The report assigns a "Sell" rating to Aier Eye Hospital Group due to missed expectations and lack of growth visibility [16][5][12]. Core Insights - Aier reported FY24 revenue of Rmb21 billion, a 3% year-over-year increase, and a net profit of Rmb3.6 billion, reflecting a 5.9% year-over-year growth, which was below consensus estimates [1][5]. - The company experienced a significant contraction in gross profit margin in 4Q24, dropping to 38.0% from 47.0% in 4Q23, attributed to increased promotions and lower margins from newly consolidated hospitals [2][5]. - Management indicated that while there was strong growth in January and February 2025, the overall growth prospects for FY25 remain uncertain due to market conditions [1][4]. Financial Performance Summary - FY24 net profit was Rmb3.6 billion, with a diluted EPS of Rmb0.385, representing a 5.9% growth [6]. - The company expects revenue growth to be driven primarily by small hospitals in the domestic market, while overseas expansion lacks visibility [4][5]. - The target price is maintained at Rmb7, with the stock trading at a P/E ratio of 28x for FY25, indicating a stretched valuation given the limited growth visibility [5][17]. Revenue and Earnings Estimates - Revenue estimates for FY25E and FY26E have been fine-tuned, with projected revenues of Rmb23.1 billion and Rmb24.9 billion respectively [5][12]. - The report anticipates a core net profit of Rmb4.3 billion for FY25E, reflecting a 20.7% growth [6][12].